Article Text

PDF
Functional imaging of the cerebral olfactory system in patients with Parkinson’s disease
  1. B Westermann1,2,
  2. E Wattendorf2,3,
  3. U Schwerdtfeger2,
  4. A Husner2,
  5. P Fuhr4,
  6. O Gratzl1,
  7. T Hummel5,
  8. D Bilecen6,
  9. A Welge-Lüssen2
  1. 1
    Neurosurgical University Clinic, University Hospital Basel, Switzerland
  2. 2
    University Clinic of Otorhinolaryngology, University Hospital Basel, Switzerland
  3. 3
    Institute of Anatomy, Department of Neuroanatomy, University of Basel, Switzerland
  4. 4
    Neurological University Clinic, University Hospital Basel, Switzerland
  5. 5
    Smell and Taste Clinic, Department of Otorhinolaryngology, University of Dresden Medical School, Dresden, Germany
  6. 6
    Institute of Radiology, University Hospital Basel, Switzerland
  1. Dr B Westermann, Neurosurgical University Clinic, University Hospital Basel, Spitalstrasse 21, Switzerland; Birgit.Westermann{at}unibas.ch

Abstract

Background: Olfactory dysfunction is a frequent non-motor symptom in Parkinson’s disease (PD) and is considered to be an early manifestation of the disease.

Objective: To establish the cortical basis of olfactory function in patients with PD.

Method: Functional magnetic resonance imaging (fMRI) was used to investigate brain activity related to olfactory processing in patients with hyposmic PD at mild to moderate stages of the disease (n = 12, median Hoehn and Yahr stage 2.0) and in healthy, age-matched controls (n = 16) while passively perceiving a positively valenced (rose-like) odorant.

Results: In both patients with PD and healthy controls, olfactory stimulation activated brain regions relevant for olfactory processing (ie the amygdaloid complex, lateral orbitofrontal cortex, striatum, thalamus, midbrain and the hippocampal formation). In controls, a bilateral activation of the amygdala and hippocampus was observed, whereas patients with PD involved these structures in the left hemisphere only. Group comparison showed that regions of higher activation in patients with PD were located bilaterally in the inferior frontal gyrus (BA 44/45) and anterior cingulate gyrus (BA 24/32), and the left dorsal and right ventral striatum.

Conclusions: In patients with PD, results obtained under the specific conditions used suggest that neuronal activity in the amygdala and hippocampus is reduced. Assuming an impact on olfactory-related regions early in PD, our findings support the idea that selective impairment of these brain regions contributes to olfactory dysfunction. Furthermore, neuronal activity in components of the dopaminergic, cortico-striatal loops appears to be upregulated, indicating that compensatory processes are involved. This mechanism has not yet been demonstrated during olfactory processing in PD.

  • Parkinson’s disease
  • olfactory dysfunction
  • laterality
  • functional magnetic resonance imaging (fMRI)

Statistics from Altmetric.com

Footnotes

  • Funding: This study was supported by grants from the Swiss National Science Foundation (Grant No. 3100-068282 and 3100A0-100633).

  • Competing interests: None declared.

  • Ethics approval: The study was approved by the Ethics Committee of the University Hospital of Basel, Switzerland.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.